UCB Frustrated By FDA Failure To Inspect Facility For Psoriasis Drug

Delays Expected Approval Of Bimekizumab

 
• By Kevin Grogan
  
travel disrupt
COVID-19 travel restrictions prevented inspection of UCB facility • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip